Immunic, Inc. (IMUX)
8.20
+0.64
(+8.47%)
USD |
NASDAQ |
Oct 09, 16:00
8.13
-0.07
(-0.85%)
After-Hours: 20:00
Immunic Free Cash Flow : -88.05M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -88.05M |
| March 31, 2026 | -81.45M |
| December 31, 2025 | -85.97M |
| September 30, 2025 | -89.64M |
| June 30, 2025 | -90.29M |
| March 31, 2025 | -82.85M |
| December 31, 2024 | -85.03M |
| September 30, 2024 | -76.26M |
| June 30, 2024 | -72.76M |
| March 31, 2024 | -75.54M |
| December 31, 2023 | -71.16M |
| September 30, 2023 | -72.07M |
| June 30, 2023 | -68.39M |
| March 31, 2023 | -64.18M |
| December 31, 2022 | -65.26M |
| September 30, 2022 | -73.85M |
| June 30, 2022 | -77.80M |
| March 31, 2022 | -91.04M |
| December 31, 2021 | -83.30M |
| September 30, 2021 | -73.59M |
| June 30, 2021 | -67.94M |
| March 31, 2021 | -48.20M |
| December 31, 2020 | -46.27M |
| September 30, 2020 | -38.84M |
| June 30, 2020 | -32.86M |
| Date | Value |
|---|---|
| March 31, 2020 | -34.58M |
| December 31, 2019 | -28.87M |
| September 30, 2019 | -25.78M |
| June 30, 2019 | -21.88M |
| March 31, 2019 | -1.87M |
| December 31, 2018 | -9.77M |
| September 30, 2018 | -16.34M |
| June 30, 2018 | -23.83M |
| March 31, 2018 | -43.12M |
| December 31, 2017 | -41.08M |
| September 30, 2017 | -40.27M |
| June 30, 2017 | -38.85M |
| March 31, 2017 | -37.43M |
| December 31, 2016 | -36.33M |
| September 30, 2016 | -36.45M |
| June 30, 2016 | -40.64M |
| March 31, 2016 | -48.19M |
| December 31, 2015 | -52.29M |
| September 30, 2015 | -53.39M |
| June 30, 2015 | -52.55M |
| March 31, 2015 | -46.24M |
| December 31, 2014 | -42.23M |
| September 30, 2014 | -42.24M |
| June 30, 2014 | -39.45M |
| March 31, 2014 | -35.63M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Sionna Therapeutics, Inc. | -76.21M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.00M |
| Cash from Investing (Quarterly) | -0.249M |
| Cash from Financing (Quarterly) | 0.118M |
| Free Cash Flow Per Share (Quarterly) | -0.735 |
| Free Cash Flow to Equity (Quarterly) | -31.39M |
| Free Cash Flow to Firm (Quarterly) | -31.25M |
| Free Cash Flow Yield | -41.27% |